IBEX (NASDAQ:IBEX – Get Free Report) will likely be announcing its Q1 2027 results after the market closes on Thursday, November 5th. Analysts expect the company to post earnings of $0.90 per share and revenue of $169.31 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q1 2027 earnings report page for the latest details on the call scheduled for Thursday, November 5, 2026 at 4:30 PM ET.
IBEX (NASDAQ:IBEX – Get Free Report) last issued its quarterly earnings results on Friday, September 11th. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.01. IBEX had a net margin of 7.19% and a return on equity of 28.96%. The business had revenue of $164.27 million for the quarter, compared to analysts’ expectations of $160.02 million.
IBEX Trading Down 0.6%
IBEX stock opened at $45.65 on Thursday. IBEX has a twelve month low of $25.94 and a twelve month high of $48.17. The stock’s fifty day simple moving average is $41.80 and its 200-day simple moving average is $34.25. The firm has a market capitalization of $606.23 million, a P/E ratio of 14.58 and a beta of 0.69.
Insider Activity at IBEX
In other news, insider Christina O’Connor sold 7,500 shares of the firm’s stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $40.30, for a total value of $302,250.00. Following the completion of the sale, the insider owned 29,231 shares in the company, valued at approximately $1,178,009.30. This trade represents a 20.42% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Robert Dechant sold 25,000 shares of IBEX stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $39.99, for a total value of $999,750.00. Following the completion of the sale, the chief executive officer directly owned 262,011 shares in the company, valued at $10,477,819.89. This represents a 8.71% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 97,465 shares of company stock worth $3,882,291 in the last three months. Company insiders own 3.40% of the company’s stock.
Analyst Ratings Changes
IBEX has been the subject of several analyst reports. Wall Street Zen cut IBEX from a “strong-buy” rating to a “buy” rating in a research report on Saturday, September 12th. Robert W. Baird increased their price objective on IBEX from $40.00 to $44.00 and gave the company a “neutral” rating in a report on Monday, September 28th. Finally, Weiss Ratings raised IBEX from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, October 12th. One research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $42.00.
Get Our Latest Research Report on IBEX
About IBEX
IBEX Limited (NASDAQ: IBEX) is a business process outsourcing and customer experience technology company. It provides customer service, technical support, sales, back-office processing and other digital services for businesses across industries, including communications, healthcare, retail, logistics and financial services.
The company combines customer contact centers, digital engagement channels, analytics and artificial intelligence-enabled tools to help clients manage customer interactions and improve operational efficiency.
Featured Stories
- Five stocks we like better than IBEX
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for IBEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBEX and related companies with MarketBeat.com's FREE daily email newsletter.
